Ampio Pharma Announces Responses to Questions Related to STEP Study

By: via Benzinga
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) today is issuing this response to the most commonly asked questions in regards to the STEP ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.